These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38271762)

  • 41. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study.
    Yoosefi A; Sepehri AS; Kargar M; Akhondzadeh S; Sadeghi M; Rafei A; Alimadadi A; Ghaeli P
    J ECT; 2014 Mar; 30(1):15-21. PubMed ID: 24091902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression.
    Rybakowski JK; Bodnar A; Krzywotulski M; Chlopocka-Wozniak M; Michalak M; Rosada-Kurasinska J; Bartkowska-Sniatkowska A
    J ECT; 2016 Sep; 32(3):164-8. PubMed ID: 27008330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ketamine and other glutamate receptor modulators for depression in adults.
    Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial.
    Fernie G; Currie J; Perrin JS; Stewart CA; Anderson V; Bennett DM; Hay S; Reid IC
    Br J Psychiatry; 2017 Jun; 210(6):422-428. PubMed ID: 28254962
    [No Abstract]   [Full Text] [Related]  

  • 45. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
    Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM
    BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.
    Altinay M; Karne H; Anand A
    Psychopharmacol Bull; 2019 Feb; 49(1):8-16. PubMed ID: 30858635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
    Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketamine versus electroconvulsive therapy for major depressive episode: An updated systematic review and non-inferiority meta-analysis.
    Petrucci ABC; Fernandes JVA; Reis IA; da Silva GHS; Recla BMF; de Mendonça JC; Pedro VCS; D'Assunção LEN; Valiengo LDCL
    Psychiatry Res; 2024 May; 339():115994. PubMed ID: 38865906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review.
    Veraart JKE; Smith-Apeldoorn SY; Spaans HP; Kamphuis J; Schoevers RA
    J Affect Disord; 2021 Feb; 281():82-89. PubMed ID: 33307338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Randomized Pilot Study Comparing Ketamine and Methohexital Anesthesia for Electroconvulsive Therapy in Patients With Depression.
    Ray-Griffith SL; Eads LA; Han X; Golden K; Stowe ZN
    J ECT; 2017 Dec; 33(4):268-271. PubMed ID: 28422805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
    Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
    BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical efficacy of adjunctive esketamine anesthesia in electroconvulsive therapy for major depressive disorders: A pragmatic, randomized, controlled trial.
    Ren L; Chen Q; Gao J; Liu Y; Tao Y; Li X; Luo Q; Lv F; Min S
    Psychiatry Res; 2024 May; 335():115843. PubMed ID: 38461645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A retrospective comparison of the effects of propofol and etomidate on stimulus variables and efficacy of electroconvulsive therapy in depressed inpatients.
    Graveland PE; Wierdsma AI; van den Broek WW; Birkenhäger TK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():230-5. PubMed ID: 23774194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Some considerations of the tolerability of ketamine for ECT anesthesia: a case series and review of the literature.
    Rasmussen KG; Ritter MJ
    J ECT; 2014 Dec; 30(4):283-6. PubMed ID: 24820945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial.
    Loo CK; Katalinic N; Garfield JB; Sainsbury K; Hadzi-Pavlovic D; Mac-Pherson R
    J Affect Disord; 2012 Dec; 142(1-3):233-40. PubMed ID: 22858219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials.
    Li XM; Shi ZM; Wang PJ; Hu H
    Gen Psychiatr; 2020; 33(3):e100117. PubMed ID: 32596639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparing the Anti-Depressive Effect of Electroconvulsive Therapy (ECT) Versus Transcranial Magnetic Stimulation (TMS) in the Treatment of Patients with Depression.
    Chigareva O; Smirnova D; Astafeva D; Gradinar A; Izmailova O; Sheyfer M; Cumming P; Sack A; Gayduk AJ
    Psychiatr Danub; 2023 Oct; 35(Suppl 2):48-55. PubMed ID: 37800203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of ketamine in ECT anaesthesia: A systematic review and critical commentary on efficacy, cognitive, safety and seizure outcomes.
    Gálvez V; McGuirk L; Loo CK
    World J Biol Psychiatry; 2017 Sep; 18(6):424-444. PubMed ID: 27892759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term cognitive effects of electroconvulsive therapy in major depressive disorder: A systematic review and meta-analysis.
    Guo Q; Wang Y; Guo L; Li X; Ma X; He X; Li J; Zhang X; Shang S
    Psychiatry Res; 2024 Jan; 331():115611. PubMed ID: 38101070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.
    Gonçalves CL; Abelaira HM; Rosa T; de Moura AB; Veron DC; Borba LA; Botelho MEM; Goldim MP; Garbossa L; Fileti ME; Petronilho F; Ignácio ZM; Quevedo J; Réus GZ
    Pharmacol Rep; 2021 Apr; 73(2):525-535. PubMed ID: 33393059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.